V011-1917 Screening compound: N-[1-(adamantane-1-carbonyl)piperidin-4-yl]-2-[N-(3-methylbutyl)propane-1-sulfonamido]-N-[(2-methylphenyl)methyl]acetamide

V011-1917 Screening compound: N-[1-(adamantane-1-carbonyl)piperidin-4-yl]-2-[N-(3-methylbutyl)propane-1-sulfonamido]-N-[(2-methylphenyl)methyl]acetamide
V011-1917 Screening compound: N-[1-(adamantane-1-carbonyl)piperidin-4-yl]-2-[N-(3-methylbutyl)propane-1-sulfonamido]-N-[(2-methylphenyl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V011-1917
N-[1-(adamantane-1-carbonyl)piperidin-4-yl]-2-[N-(3-methylbutyl)propane-1-sulfonamido]-N-[(2-methylphenyl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V011-1917

Molecular Formula

C34H53N3O4S (C34 H53 N3 O4 S)

Compound Name

N-[1-(adamantane-1-carbonyl)piperidin-4-yl]-2-[N-(3-methylbutyl)propane-1-sulfonamido]-N-[(2-methylphenyl)methyl]acetamide

IUPAC name

N-[1-(adamantane-1-carbonyl)piperidin-4-yl]-2-[N-(3-methylbutyl)propane-1-sulfonamido]-N-[(2-methylphenyl)methyl]acetamide

SMILES

CCCS(N(CCC(C)C)CC(N(Cc1c(C)cccc1)C(CC1)CCN1C(C1(CC(C2)C3)CC3CC2C1)=O)=O)(=O)=O

InChI

InChI=1S/C34H53N3O4S/c1-5-16-42(40,41)36(15-10-25(2)3)24-32(38)37(23-30-9-7-6-8-26(30)4)31-11-13-35(14-12-31)33(39)34-20-27-17-28(21-34)19-29(18-27)22-34/h6-9,25,27-29,31H,5,10-24H2,1-4H3

InChI Key

AFXOWBOZOIROOX-UHFFFAOYSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

599.88

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

7.178

Distribution Coefficient, logD

7.178

Water Solubility, LogSw

-5.74

Polar Surface Area

63.176

Acid Dissociation Constant (pKa)

22.17

Base Dissociation Constant (pKb)

-0.09

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

76.50

V011-1917 in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

CORONAVIRUS Library (20774 compounds)

Anti-HIV1 Library (19540 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V011-1917 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V011-1917?
Check Price and Availability of V011-1917, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V011-1917 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V011-1917
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V011-1917
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V011-1917 available by request